UBS Group’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Sell
126,094
-54,149
-30% -$249K ﹤0.01% 6034
2026
Q1
$680K Buy
180,243
+31,863
+21% +$172K ﹤0.01% 5836
2025
Q4
$1.18M Buy
148,380
+69,406
+88% +$443K ﹤0.01% 5432
2025
Q3
$272K Buy
78,974
+9,591
+14% +$35.7K ﹤0.01% 6491
2025
Q2
$287K Buy
69,383
+10,256
+17% +$34.2K ﹤0.01% 6468
2025
Q1
$142K Sell
59,127
-2,285,975
-97% -$6.44M ﹤0.01% 6776
2024
Q4
$8.54M Sell
2,345,102
-187,221
-7% -$853K ﹤0.01% 3237
2024
Q3
$16M Sell
2,532,323
-323,527
-11% -$2.18M ﹤0.01% 2007
2024
Q2
$19M Sell
2,855,850
-15,914
-0.6% -$94.1K ﹤0.01% 1723
2024
Q1
$15.2M Sell
2,871,764
-24,194
-0.8% -$114K ﹤0.01% 1917
2023
Q4
$14.9M Buy
2,895,958
+2,881,750
+20,283% +$8.89M ﹤0.01% 1794
2023
Q3
$47.9K Sell
14,208
-6,012
-30% -$39.5K ﹤0.01% 6313
2023
Q2
$167K Buy
20,220
+10,109
+100% +$91K ﹤0.01% 5606
2023
Q1
$88.4K Buy
10,111
+4,187
+71% +$46.5K ﹤0.01% 5999
2022
Q4
$72.3K Sell
5,924
-18,664
-76% -$177K ﹤0.01% 6411
2022
Q3
$156K Buy
+24,588
New +$208K ﹤0.01% 5321
2022
Q2
Sell
-1,336
Closed -$15K 10866
2022
Q1
$15K Sell
1,336
-2,504
-65% -$38.5K ﹤0.01% 7843
2021
Q4
$67K Buy
+3,840
New +$84.3K ﹤0.01% 6663

Other funds holding SGHT

UBS Group's SGHT Position: Q2 2026 in Review

UBS Group reduced its Sight Sciences (SGHT) stake by 30% in Q2 2026, selling an estimated $249K and leaving 126,094 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #6034.

UBS Group first reported a position in SGHT in Q4 2021 and has held it in 18 quarters since. The position peaked at $19M in Q2 2024. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • UBS Group held 126,094 shares of Sight Sciences worth $683K as of Q2 2026.
  • UBS Group sold 54,149 Sight Sciences shares in Q2 2026, an estimated $249K.
  • Sight Sciences made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6034 holding.
  • UBS Group first reported a position in Sight Sciences in Q4 2021 and has held it in 18 quarters since.
  • UBS Group's Sight Sciences position peaked at $19M in Q2 2024.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.